Breaking News Instant updates and real-time market news.

BIIB

Biogen

$278.36

3.28 (1.19%)

07:32
07/14/17
07/14
07:32
07/14/17
07:32

Biogen to present data at AAIC

Biogen will present data from its Alzheimer's disease programs at the Alzheimer's Association International Conference 2017 in London, July 16 to July 20. The planned poster presentations include: Change from Baseline in Clinical Dementia Rating Scale Cognitive and Functional Domains in PRIME, a Randomized Phase 1b Study of the Anti-Amyloid Beta Monoclonal Antibody Aducanumab. Poster 1-053: July 16, 2017, 9:30 a.m. GMT+1. This new post-hoc analysis shows the change in the cognitive and functional subscores, which are derived from the previously reported clinical dementia rating score for the overall and early Alzheimer's disease populations in the 1, 3, 6 and 10 mg/kg aducanumab fixed-dosing cohorts in Phase 1b. This poster will be available concurrently with the session on the Investors section of the Biogen company website, www.Biogen.com. Signs and Symptoms of Alzheimer's Disease Noted in Health Records up to 5 Years Prior to Diagnosis. Poster 2-275: July 17, 2017, 9:30 a.m. GMT+1. This analysis reports the documentation of cognitive and behavioral impairment from U.S. medical health records, prior to an Alzheimer's disease diagnosis.

  • 16

    Jul

  • 25

    Jul

BIIB Biogen
$278.36

3.28 (1.19%)

07/10/17
JEFF
07/10/17
INITIATION
Target $310
JEFF
Hold
Biogen assumed with a Hold at Jefferies
Jefferies analyst Michael Yee assumed coverage on Biogen with a Hold and a $310 price target.
06/23/17
DBAB
06/23/17
INITIATION
Target $315
DBAB
Buy
Biogen initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Andrew Peters started Biogen with a Buy rating and $315 price target, as he sees meaningful top-line growth driven by the pipeline and recently approved products and also expects margin expansion. Peters also hold a favorable view on Biogen's pipeline optionality, he tells investors.
06/22/17
LEER
06/22/17
NO CHANGE
LEER
Leerink sees reasons for biotech rally to continue
Leerink analyst Geoffrey Porges attributes the recent strength in the biotech sector to a lessening of the perceived fears of pricing regulations and a favorable tone from the FDA. However, he believes the sector could advance at least 15% more, as he foresees more positive operating results and still expects more industry consolidation. Among large cap biotech names, Porges maintains Outperform ratings on Regeneron (REGN), Celgene (CELG), Vertex (VRTX) and Alexion(ALXN) and keeps Market Perform ratings on AbbVie (ABBV), Amgen (AMGN), Gilead (GILD) and Biogen (BIIB).
06/19/17
06/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Neutral from Sell at UBS with analyst Carter Gould saying he sees an improved risk/reward and a positive near-term setup going into the second quarter earnings call and strategic review. 2. Clovis (CLVS) upgraded to Neutral from Sell at Chardan. 3. Cedar Fair (FUN) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Christopher Prykull saying early season indicators appear strong as several management teams noted ongoing leisure strength at the firm's Lodging, Gaming Restaurant and Leisure Conference. 4. Athene Holding (ATH) upgraded to Outperform from Neutral at Credit Suisse with analyst John Nadel saying he believes the probability is increasing that Athene will use acquisitions to accelerate its balance sheet and earnings growth. 5. Credit Suisse (CS) upgraded to Buy from Hold at Deutsche Bank with analyst Kinner Lakhani saying an inflection in the company's operating results is near following the recent anticipated capital raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BOJA

Bojangles

$12.50

0.1 (0.81%)

08:26
10/20/17
10/20
08:26
10/20/17
08:26
Downgrade
Bojangles rating change  »

Bojangles downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEAM

Atlassian

$40.25

0.44 (1.11%)

08:25
10/20/17
10/20
08:25
10/20/17
08:25
Recommendations
Atlassian analyst commentary  »

Atlassian price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$189.27

2.12 (1.13%)

08:25
10/20/17
10/20
08:25
10/20/17
08:25
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

08:25
10/20/17
10/20
08:25
10/20/17
08:25
General news
Fed funds futures are lower as safe haven flows unwind as risk appetite jumps »

Fed funds futures are…

WBC

Wabco

$155.08

6.01 (4.03%)

08:23
10/20/17
10/20
08:23
10/20/17
08:23
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.78

-8.21 (-12.08%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Recommendations
United Continental analyst commentary  »

Limited visibility keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.60

0.06 (0.39%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

$DJT

DJ Transportation Average

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$177.87

-0.23 (-0.13%)

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$60.69

-0.18 (-0.30%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$67.64

-0.21 (-0.31%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
10/20/17
10/20
08:20
10/20/17
08:20
General news
Canada CPI preview »

Canada CPI preview:…

XLB

S&P Select Materials SPDR

$58.24

0.22 (0.38%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.82

0.57 (1.05%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.03

-0.29 (-0.53%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.03

-1.06 (-4.22%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Recommendations
Skechers analyst commentary  »

Evercore ISI initiates a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.79

0.51 (0.61%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$149.29

-0.23 (-0.15%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$15.16

5.69 (60.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Technical View: uniQure hits fresh 52-week highs, levels to watch »

The stock is up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$231.47

0.19 (0.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$255.79

0.07 (0.03%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.33

0.02 (0.08%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.